Refine your search
17 trials found for Breast cancer, Breast Neoplasm
All(17)
Recruiting(14)
Not yet recruiting(3)
Recruiting
NCT06206837
A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
Breast Cancer
Male or Female
18+ years
114study location(s)
Recruiting
nct03445637
post marketing surveillance study to observe safety and efficacy of ibrance®
breast neoplasm
female
18+ years
2study location(s)
Recruiting
NCT04654208
Swedish Ibrance Registries Insights (SIRI)
Malignant Neoplasm of Breast
Male or Female
18 - 99 years
1study location(s)
Recruiting
NCT04937660
Treatment Patterns & Clinical Outcomes of Palbociclib Combinations in HR+HER2-MBC
Metastatic Breast Cancer
Male or Female
18 - 90 years
12study location(s)
Mar 31, 2025 - Planned start date (Not yet recruiting)
nct06873191
a study to learn more about tukysa once it is out in the korean market
her2-positive locally advanced unresectable, metastatic breast cancer
all
18+ years
1study location(s)
Apr 30, 2025 - Planned start date (Not yet recruiting)
nct06735742
a study to learn about the safety of talzenna for the treatment of breast cancer
breast cancer
all
0+ years
1study location(s)
Dec 31, 2025 - Planned start date (Not yet recruiting)
nct04982848
korea post marketing surveillance (pms) study of talzenna®
breast neoplasms
all
19+ years
1study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
All(17)
Recruiting(14)
Not yet recruiting(3)
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.